Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:49 PM
Ignite Modification Date:
2025-12-24 @ 3:49 PM
NCT ID:
NCT04283292
Eligibility Criteria:
Inclusion Criteria:
* At least 18 years old
* Diagnosis of cannabinoid hyperemesis syndrome
Exclusion Criteria:
* Patients who receive more than 2 anti-emetic therapies prior to screening for enrollment
* Patients who receive haloperidol as an anti-emetic therapy
* Pregnant women
* Prisoners
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04283292
Study Brief:
Protocol Section:
NCT04283292